Immune CPIs in NSCLC: Durvalumab After cCRT for Stage III, 2L Nivo, Pembro & Atezo for Advanced Disease
By
CECOG Academy
FEATURING
Wolfgang Kostler
By
CECOG Academy
FEATURING
Wolfgang Kostler
Comments 0
Login to view comments.
Click here to Login
